Catalyst Wire Dossier Catalyst Wire Dossier

AIN457

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for AIN457, covering 2010-04-09 to 2021-07-12. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease [Phase 2]

See pricing